Sean D. Donevan - Concepedia

Author

Sean D. Donevan

Also Known As

S D Donevan, S Donevan, S. D. Donevan, S. Donevan, S.D Donevan, S.D. Donevan, Sean D. Donevan, Sean Donevan, Sean D. Donevan

Publications

3.6K

Citations

H-Index

Concepts

All Affiliations

National Institutes of Health National Institute of Neurological Disorders and Stroke University of Utah Pfizer (United States)Queen's University

About

Sean D. Donevan is an author at National Institutes of Health specializing in medicine, pharmacology, and neuropharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	15	1.5K
2	Social Sciences	6	6	754
3	Health Sciences	2	2	81
4	Natural Sciences	1	1	45
5	Public Health	1	1	65

Sean D. Donevan

Publications

2.7K

Citations

H-Index

Page 1

	Year	Citations
GYKI 52466, a 2,3-benzodiazepine, is a highly selective, noncompetitive antagonist of AMPA/kainate receptor responses Sean D. Donevan, Michael A. Rogawski Neuron Noncompetitive AntagonistFunctional SelectivityMedicinePhysiologyGyki 52466	1993	358
Intracellular polyamines mediate inward rectification of Ca(2+)-permeable alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors. Sean D. Donevan, Michael A. Rogawski Proceedings of the National Academy of Sciences Synaptic TransmissionNeurotransmitterNeurotransmissionIntracellular PolyaminesCellular Physiology	1995	231
Direct activation of GABAA receptors by barbiturates in cultured rat hippocampal neurons. Jong M. Rho, Sean D. Donevan, Michael A. Rogawski The Journal of Physiology	1996	185
Mechanism of action of the anticonvulsant felbamate: Opposing effects on <i>N</i>‐methyl‐<scp>D</scp>‐aspartate and γ‐aminobutyric acid<sub>A</sub> receptors Jong M. Rho, Sean D. Donevan, Michael A. Rogawski Annals of Neurology Synaptic TransmissionAnimal Seizure ModelsNeuromodulation TherapiesNeurotransmitterNeurotransmission	1994	184
Acetoacetate, Acetone, and Dibenzylamine (a Contaminant in <scp>l</scp>‐(+)‐β‐Hydroxybutyrate) Exhibit Direct Anticonvulsant Actions in Vivo Jong M. Rho, Gail D. Anderson, Sean D. Donevan, Epilepsia	2002	154
Pregabalin is a potent and selective ligand for α2δ-1 and α2δ-2 calcium channel subunits Zheng Li, Charles P. Taylor, Mark L. Weber, European Journal of Pharmacology Molecular PharmacologySignal TransductionMolecular PhysiologyBiochemistryMedicine	2011	147
Anticonvulsant activity of AMPA/kainate antagonists: comparison of GYKI 52466 and NBQX in maximal electroshock and chemoconvulsant seizure models Shun‐ichi Yamaguchi, Sean D. Donevan, Michael A. Rogawski Epilepsy Research Ampa/kainate AntagonistsNeurophysiologyMedicineAnticonvulsant ActivityGyki 52466	1993	143
AMPA receptors in epilepsy and as targets for antiepileptic drugs. Michael A. Rogawski, Sean D. Donevan PubMed Molecular PharmacologySeizure SpreadNeurophysiologyMedicineSynaptic Transmission	1999	111
Conantokin G Is an NR2B-Selective Competitive Antagonist of<i>N</i>-Methyl-d-aspartate Receptors Sean D. Donevan, R. Tyler McCabe Molecular Pharmacology	2000	109
Non-N-methyl-D-aspartate receptor antagonism by 3-N-substituted 2,3-benzodiazepines: relationship to anticonvulsant activity. Sean D. Donevan, Satoshi Yamaguchi, Michael A. Rogawski Journal of Pharmacology and Experimental Therapeutics	1994	96

Page 1